Oncimmune Holdings (LSE:ONC) 3-Year EBITDA Growth Rate : 24.50% (As of Feb. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Oncimmune Holdings 3-Year EBITDA Growth Rate?

Oncimmune Holdings's EBITDA per Share for the six months ended in Feb. 2024 was £-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 24.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.00% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Oncimmune Holdings was 24.50% per year. The lowest was -62.20% per year. And the median was -1.95% per year.

Competitive Comparison of Oncimmune Holdings's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Oncimmune Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncimmune Holdings's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncimmune Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Oncimmune Holdings's 3-Year EBITDA Growth Rate falls into.

Oncimmune Holdings 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Oncimmune Holdings (LSE:ONC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Oncimmune Holdings 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Oncimmune Holdings's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncimmune Holdings (LSE:ONC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncimmune Holdings PLC (LSE:ONC) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

OCY:Germany

Address

1 Park Row, MediCity - D6 Building, Leeds, GBR, LS1 5AB

Website

https://www.oncimmune.com

Oncimmune Holdings PLC is engaged in diagnosing cancer. It is involved in the development, manufacture, and commercialization of personalized immunodiagnostics for the screening, detection and care of cancer. The company's operating segment includes Early CDT Lung and ImmunoINSIGHTS.

Oncimmune Holdings (LSE:ONC) Headlines

No Headlines